title: The murine gammaherpesvirus immediate-early Rta synergizes with IRF4, targeting expression of the viral M1 superantigen to plasma cells.
abstract: MHV68 is a murine gammaherpesvirus that infects laboratory mice and thus provides a tractable small animal model for characterizing critical aspects of gammaherpesvirus pathogenesis. Having evolved with their natural host, herpesviruses encode numerous gene products that are involved in modulating host immune responses to facilitate the establishment and maintenance of lifelong chronic infection. One such protein, MHV68 M1, is a secreted protein that has no known homologs, but has been shown to play a critical role in controlling virus reactivation from latently infected macrophages. We have previous demonstrated that M1 drives the activation and expansion of Vβ4+ CD8+ T cells, which are thought to be involved in controlling MHV68 reactivation through the secretion of interferon gamma. The mechanism of action and regulation of M1 expression are poorly understood. To gain insights into the function of M1, we set out to evaluate the site of expression and transcriptional regulation of the M1 gene. Here, using a recombinant virus expressing a fluorescent protein driven by the M1 gene promoter, we identify plasma cells as the major cell type expressing M1 at the peak of infection in the spleen. In addition, we show that M1 gene transcription is regulated by both the essential viral immediate-early transcriptional activator Rta and cellular interferon regulatory factor 4 (IRF4), which together potently synergize to drive M1 gene expression. Finally, we show that IRF4, a cellular transcription factor essential for plasma cell differentiation, can directly interact with Rta. The latter observation raises the possibility that the interaction of Rta and IRF4 may be involved in regulating a number of viral and cellular genes during MHV68 reactivation linked to plasma cell differentiation.
authors.affiliation: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America; Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.
authors.forename: Brigid M
authors.initials: BM
authors.lastname: O'Flaherty
authors.affiliation: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America; Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.
authors.forename: Tanushree
authors.initials: T
authors.lastname: Soni
authors.affiliation: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America; Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.
authors.forename: Brian S
authors.initials: BS
authors.lastname: Wakeman
authors.affiliation: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America; Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.
authors.forename: Samuel H
authors.initials: SH
authors.lastname: Speck
mesh_terms: D000818:Animals; D024202:Electrophoretic Mobility Shift Assay; D005260:Female; D005434:Flow Cytometry; D018142:Gammaherpesvirinae; D015967:Gene Expression Regulation, Viral; D006566:Herpesviridae Infections / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D006790:Host-Parasite Interactions; D017874:Immediate-Early Proteins; D047468:Immunoprecipitation; D050835:Interferon Regulatory Factors; D051379:Mice; D008810:Mice, Inbred C57BL; D010950:Plasma Cells / Q000378:metabolism / Q000821:virology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018089:Superantigens / Q000235:genetics / Q000378:metabolism*; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism*; D014775:Virus Activation / Q000502:physiology; D017735:Virus Latency / Q000502:physiology; D000099218:Interferon Regulatory Factor-4
chemical_list: D017874:Immediate-Early Proteins; D050835:Interferon Regulatory Factors; D018089:Superantigens; D014764:Viral Proteins; D000099218:Interferon Regulatory Factor-4
references.citation: Cell Host Microbe. 2010 Jun 25;7(6):516-26
references.pmid: 20542255
references.citation: PLoS Pathog. 2008 Apr 04;4(4):e1000039
references.pmid: 18389062
references.citation: J Virol. 1997 Dec;71(12):9124-33
references.pmid: 9371569
references.citation: J Virol. 2007 Dec;81(24):13578-86
references.pmid: 17928342
references.citation: J Exp Med. 1996 Sep 1;184(3):971-80
references.pmid: 9064357
references.citation: J Virol. 1996 Oct;70(10):6775-80
references.pmid: 8794315
references.citation: Immunity. 2001 Oct;15(4):579-89
references.pmid: 11672540
references.citation: J Virol. 2006 Jan;80(1):192-200
references.pmid: 16352543
references.citation: J Virol. 2007 Aug;81(16):8451-67
references.pmid: 17537858
references.citation: J Virol. 2007 Jun;81(11):6134-40
references.pmid: 17360749
references.citation: J Virol. 2002 Feb;76(4):1790-801
references.pmid: 11799175
references.citation: J Gen Virol. 1998 Jan;79 ( Pt 1):149-53
references.pmid: 9460936
references.citation: J Virol. 2011 Nov;85(22):11901-15
references.pmid: 21880753
references.citation: J Immunol. 1999 Aug 1;163(3):1481-9
references.pmid: 10415050
references.citation: J Virol. 1999 Nov;73(11):9650-4
references.pmid: 10516078
references.citation: FEMS Microbiol Lett. 2003 May 28;222(2):155-63
references.pmid: 12770701
references.citation: J Virol. 2003 Jul;77(13):7308-18
references.pmid: 12805429
references.citation: J Exp Med. 1997 May 5;185(9):1641-50
references.pmid: 9151901
references.citation: J Virol. 2005 Feb;79(4):2261-73
references.pmid: 15681428
references.citation: J Virol. 2014 May;88(10):5474-90
references.pmid: 24574412
references.citation: FEBS Lett. 2007 Jul 24;581(18):3485-8
references.pmid: 17617410
references.citation: Front Microbiol. 2012 Feb 14;3:30
references.pmid: 22347875
references.citation: PLoS Pathog. 2014 May 01;10(5):e1004106
references.pmid: 24789087
references.citation: J Virol. 2002 Jun;76(12):6244-56
references.pmid: 12021358
references.citation: PLoS Pathog. 2009 Nov;5(11):e1000677
references.pmid: 19956661
references.citation: J Gen Virol. 2003 Jan;84(Pt 1):99-109
references.pmid: 12533705
references.citation: J Virol. 2008 Aug;82(15):7688-99
references.pmid: 18495760
references.citation: J Virol. 2009 Jul;83(13):6484-93
references.pmid: 19386718
references.citation: J Virol. 2000 Feb;74(4):1973-84
references.pmid: 10644370
references.citation: J Virol. 2005 Jan;79(2):1296-307
references.pmid: 15613356
references.citation: J Virol. 2003 Oct;77(19):10488-503
references.pmid: 12970434
references.citation: Immunology. 1986 Nov;59(3):405-9
references.pmid: 3025081
references.citation: J Gen Virol. 2013 Jul;94(Pt 7):1613-1623
references.pmid: 23535573
references.citation: PLoS One. 2012;7(3):e33230
references.pmid: 22427999
references.citation: J Virol. 2013 Mar;87(6):3597-604
references.pmid: 23302876
references.citation: PLoS Pathog. 2014 Jan;10(1):e1003858
references.pmid: 24391506
references.citation: J Gen Virol. 1999 Jan;80 ( Pt 1):75-82
references.pmid: 9934687
references.citation: Immunol Rev. 2012 May;247(1):73-92
references.pmid: 22500833
references.citation: J Virol. 2004 Jul;78(14):7852-60
references.pmid: 15220463
references.citation: Immunity. 2013 May 23;38(5):918-29
references.pmid: 23684984
references.citation: J Immunol. 2004 Mar 1;172(5):3078-85
references.pmid: 14978113
references.citation: Proc Natl Acad Sci U S A. 1990 May;87(10):3743-7
references.pmid: 2111015
references.citation: PLoS Pathog. 2006 Jun;2(6):e58
references.pmid: 16789842
references.citation: Immunity. 2006 Aug;25(2):225-36
references.pmid: 16919487
references.citation: J Virol. 2012 Jan;86(2):1021-33
references.pmid: 22090118
references.citation: J Virol. 2002 Jul;76(14):7125-32
references.pmid: 12072512
references.citation: J Virol. 1999 Mar;73(3):2321-32
references.pmid: 9971815
references.citation: Nat Immunol. 2006 Jul;7(7):773-82
references.pmid: 16767092
references.citation: J Virol. 2007 Dec;81(24):13566-77
references.pmid: 17898050
references.citation: J Exp Med. 2002 Nov 18;196(10):1363-72
references.pmid: 12438427
references.citation: J Exp Med. 2008 Mar 17;205(3):669-84
references.pmid: 18332178
references.citation: Viral Immunol. 2001;14(4):391-402
references.pmid: 11792068
references.citation: J Virol. 2007 Jul;81(14):7363-70
references.pmid: 17494074
references.citation: Immunity. 2009 Dec 18;31(6):941-52
references.pmid: 20064451
references.citation: Virology. 2005 Mar 1;333(1):169-79
references.pmid: 15708602
references.citation: PLoS Pathog. 2006 May;2(5):e37
references.pmid: 16733540
references.citation: J Virol. 2000 Feb;74(4):2029-37
references.pmid: 10644377
references.citation: PLoS Pathog. 2007 Jan;3(1):e11
references.pmid: 17257062